Influenza virus hemagglutinin protein H1 subtype (HA (H1))

The **influenza virus hemagglutinin protein H1 subtype** is a trimeric transmembrane glycoprotein on the surface of influenza A viruses, especially notable in H1N1 strains[1][3][5]. Each monomer consists of HA1 (globular head domain) and HA2 (stem domain) subunits, which together mediate two essential viral activities: attachment to sialic acid–containing receptors on host cells and pH-triggered fusion of the viral envelope with host endosomal membranes[1][2][3][5]. Hemagglutinin is the principal antigen recognized by the immune system, and variation in its sequence underlies both seasonal vaccine updates and the emergence of pandemic influenza strains. The H1 subtype has caused numerous pandemics, including the infamous 1918 and 2009 pandemics, and remains a primary focus for antiviral and vaccine development[1][5]. Increasing structural and antigenic variation, especially in the receptor binding domain, poses challenges for long-term efficacy of interventions[5].

Other names

Hemagglutinin (influenza)Influenza A virus hemagglutininHAH1

Vaccines: Induce neutralizing antibodies to block receptor binding and membrane fusion Monoclonal antibodies: Bind to the head or stalk domain to prevent cell entry or mediate immune clearance Fusion inhibitors: Prevent conformational change needed for viral membrane fusion